Efficacy and safety of aripiprazole once-monthly versus oral aripiprazole in Chinese patients with acute schizophrenia: a multicenter, randomized, double-blind, non-inferiority study.

Le XiaoQian ZhaoAn-Ning LiJushui SunBin WuLina WangHonggeng ZhangRuiling ZhangKeqing LiXiaojin XuTiebang LiuWenshun ZhangShiping XieXiufeng XuYunlong TanKerang ZhangHongyan ZhangNianhong GuanMingji XianMotomichi UkiGang Wang

Published in: Psychopharmacology (2022)

ClinicalTrials.gov identifier: NCT03172871.

Keyphrases

double blind
placebo controlled
clinical trial
phase iii
phase ii
bipolar disorder
open label
study protocol
randomized controlled trial